$EAPH News






Easton Pharmaceuticals Announces Update to VIORRA Initiative:
Manufacturing Set to Begin
9:32 a.m. Feb. 3, 2014
- Marketwire




TrendingWallStreet.com Releases Begins Analysis on EAPH, PHOT, CMG, and MAT
12:38 a.m. Feb. 3, 2014
- ACCESSWIRE




Easton Pharmaceuticals Moves Towards Formerly Engaging Leading Legal
Expert on Medical Marijuana Licence, as Well as Moving to Next Level
of Medical Marijuana Negotiations With Request for Term-Sheet and
Final Due Diligence Documents
8:02 a.m. Jan. 29, 2014
- Marketwire




Easton Pharmaceuticals Announces Update on Negotiations Towards Its
Medical Marijuana Initiatives
8:52 a.m. Jan. 16, 2014
- Marketwire




Easton Pharmaceuticals Provides Update on Initiatives Towards Its
Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing
Submission for "Viorra"
11:56 a.m. Dec. 11, 2013
- Marketwire




Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring
Initial Minority Ownership Interest in Experimental Cancer Drug
"XILIVE" With 12 Month Option to Purchase Remaining Interest;
Preliminary Feedback Extremely Promising
1:39 p.m. Nov. 6, 2013
- Marketwire




Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing
Update and Forward Sales Estimates for VIORRA
8:31 a.m. Nov. 4, 2013
- Marketwire




Easton Pharmaceuticals Announces Formal Agreement & Advances Payment
to BMV Medica S.A. Towards a Regulatory Filing in Mexico for
"Viorra"; Company Anticipates Approval and Initial Sales by End of
Second Quarter 2014
7:03 a.m. Oct. 22, 2013
- Marketwire




Easton Pharmaceuticals Announces Application to Obtain a
Distributorship License Towards Its Canadian Medical Marijuana
Initiatives
7:01 a.m. Oct. 4, 2013
- Marketwire




Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives
8:00 a.m. Sept. 27, 2013
- BusinessWire




Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pendings. Drug Subsequently Underwent Clinical Trials At Cedar-Sinai Medical Center, Beverley Hills, CA.
8:00 a.m. Sept. 16, 2013
- BusinessWire




Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives
7:40 a.m. Aug. 23, 2013
- Filing Services Canada




Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives
7:40 a.m. Aug. 23, 2013
- BusinessWire




Easton Pharmaceuticals Announces It Has Ordered Ingredients towards Producing Final Test and Trial Samples of Its Re-Formulated Viorra and Other Recently Added Portfolio Products
10:57 a.m. Aug. 14, 2013
- BusinessWire




Easton Pharmaceuticals Announces Three New Additional Products and a Revision to Its Viorra Flagship Product Towards Resuming Its Latin American & South East Asia Initiatives
6:09 p.m. June 7, 2013
- BusinessWire




Easton Pharmaceuticals, Inc. Announces Its Entrance into the Medical Marijuana Sector
3:25 p.m. June 5, 2013
- BusinessWire




Easton Pharmaceuticals Announces Neil Mellor as Senior Consultant, Chief Operations Officer
10:21 a.m. June 5, 2013
- BusinessWire




Easton Pharmaceuticals Announces Neil Mellor as Senior Consultant, Chief Operations Officer
4:57 p.m. June 4, 2013
- BusinessWire




Easton Pharmaceuticals Provides Corporate Update
2:09 p.m. April 9, 2013
- BusinessWire




Easton Pharmaceuticals Provides Corporate Update
7:30 a.m. April 9, 2013
- BusinessWire